Markets Gone Wild

CSL Behring’s New Monoclonal Antibody Treatment ANDEMBRY® Receives Approval in Japan CSL Behring K.K., a leading global biotherapeutics company, recently made a significant breakthrough in the treatment of Hereditary Angioedema (HAE). The company announced that it has received manufacturing and marketing approval from Japan’s Ministry of Health, Labour and Welfare (MHLW) for ANDEMBRY® (garadacimab) Subcutaneous…

Pfizer (PFE): The Stock That’s Been Making Waves at Zacks.com Hey there, curious cat! I see you’ve been keeping an eye on Pfizer (PFE) lately. Well, you’re not alone in that! This big pharma giant has been making some noise over at Zacks.com, and I thought it would be a good idea to spill the…

Cisco Systems Reports Mixed Results in Q2 2025 Earnings A Closer Look at Cisco’s Fiscal Q2 ’25 Results Cisco Systems, a leading technology company, recently reported their fiscal Q2 ’25 results after the closing bell on Wednesday, February 12th, 2025. The analyst consensus was looking for $0.91 in earnings per share on $13.87 billion in…

New Orleans, LA / ACCESS Newswire / February 13, 2025 Kahn Swick & Foti, LLC (“KSF”) Reminder for Investors Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until February 21, 2025 to file lead plaintiff applications in a securities class…